Loading...
XNASNRC
Market cap394mUSD
Jan 10, Last price  
16.79USD
1D
-3.17%
1Q
-10.98%
Jan 2017
-11.63%
Name

National Research Corp

Chart & Performance

D1W1MN
XNAS:NRC chart
P/E
12.73
P/S
2.65
EPS
1.32
Div Yield, %
9.23%
Shrs. gr., 5y
-2.55%
Rev. gr., 5y
4.42%
Revenues
149m
-1.97%
29,683,09132,436,00043,771,45548,922,88451,013,00057,692,00063,398,00075,767,00086,421,00092,590,00098,837,000102,343,000109,384,000117,559,000119,686,000127,982,000133,277,000147,954,000151,568,000148,580,000
Net income
31m
-2.61%
4,550,6345,236,0005,884,0686,839,0127,445,0008,491,0008,499,00011,564,00015,068,00015,484,00018,156,00017,610,00020,518,00022,943,00030,047,00032,406,00037,260,00037,466,00031,800,00030,971,000
CFO
38m
+5.10%
7,816,7298,188,0006,812,18014,566,11415,175,38113,666,00014,603,00018,481,00019,132,00019,315,00026,197,00021,886,00026,843,00028,091,00039,848,00040,917,00040,636,00046,344,00036,265,00038,113,000
Dividend
Sep 27, 20240.12 USD/sh
Earnings
Feb 11, 2025

Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
IPO date
Oct 01, 1997
Employees
491
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
148,580
-1.97%
151,568
2.44%
Cost of revenue
61,914
57,049
Unusual Expense (Income)
NOPBT
86,666
94,519
NOPBT Margin
58.33%
62.36%
Operating Taxes
8,991
11,015
Tax Rate
10.37%
11.65%
NOPAT
77,675
83,504
Net income
30,971
-2.61%
31,800
-15.12%
Dividends
(36,366)
(20,961)
Dividend yield
3.73%
2.24%
Proceeds from repurchase of equity
(19,099)
(27,616)
BB yield
1.96%
2.96%
Debt
Debt current
7,214
4,491
Long-term debt
32,808
18,062
Deferred revenue
Other long-term liabilities
2,001
2,047
Net debt
33,369
(2,473)
Cash flow
Cash from operating activities
38,113
36,265
CAPEX
(15,779)
(9,835)
Cash from investing activities
(15,778)
(9,835)
Cash from financing activities
(40,707)
(55,583)
FCF
69,065
78,647
Balance
Cash
6,653
25,026
Long term investments
Excess cash
17,448
Stockholders' equity
(30,499)
(25,153)
Invested Capital
119,808
121,414
ROIC
64.40%
60.89%
ROCE
92.74%
93.09%
EV
Common stock shares outstanding
24,673
25,052
Price
39.56
6.06%
37.30
-10.16%
Market cap
976,064
4.45%
934,440
-12.22%
EV
1,009,433
931,967
EBITDA
92,565
99,796
EV/EBITDA
10.91
9.34
Interest
862
1,209
Interest/NOPBT
0.99%
1.28%